Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9072710

    Injectable ibuprofen formulation

    Cumberland Pharmaceuticals Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9072709

    Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9072675

    Non-irritating benzoyl peroxide

    Essential Ingredients, Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9072661

    Injectable ibuprofen formulation

    Cumberland Pharmaceuticals Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9072752

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9073864

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9074185

    Adoptive cell therapy with young T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9073884

    Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them

    The Regents of the University of California · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9072792

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9072767

    Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

    UNITED PHARMACEUTICALS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9072716

    Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells

    The United States of America, as represented by the Secretary Department of Health by Human Servies · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9078441

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9079936

    Derivatives of APF and methods of use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9078832

    Biomimetic scaffold for bone regeneration

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9079907

    Fused heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9078918

    Inhibition of fibrosis and AF by TGF-beta inhibition in the posterior left atrium (PLA)

    Northwestern University · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9078905

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9079974

    GH-RH analogs with potent agonistic effects

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9079865

    Hydrazide containing nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9078922

    Metal-organic frameworks with exceptionally large pore aperatures

    The Regents of the University of California · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9079916

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9078881

    Salinosporamides and methods of use thereof

    The Regents of the University of California · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9078919

    Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair

    The Board of Regents of the University of Texas System · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9079898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9079944

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9079948

    Human antibodies to Fel d1 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9080175

    Organic compositions to treat Beta-ENaC-related diseases

    Arrowhead Research Corporation · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9080148

    Neuronal cells cultured on microparticles and methods of using the neuronal cells

    The Regents of the University of California · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9080174

    HBV treatment

    Benitec Biopharma Limited · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9079917

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9079913

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. WO 2015104417

    UTILISATION DU CABAZITAXEL POUR LE TRAITEMENT DE L'ADÉNOCARCINOME GASTRIQUE

    AVENTIS PHARMA SA [FR] · Granted Thu Jul 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9084830

    Microvesicles derived from cell protoplast and use thereof

    Aeon Medix Inc. · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9084783

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9084762

    T-cell immunogens derived from anti-viral proteins and methods of using same

    The Regents of the University of California · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9084795

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9084782

    Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis

    The Regents of the University of California · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9084773

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9084809

    Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9084819

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9084820

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9085578

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9085644

    Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

    The Regents of the University of California · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9085598

    Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9085604

    Antiproliferative factor and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9085659

    Polymer derivatives comprising an imide branching point

    Nektar Therapeutics · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9084746

    Therapeutic applications of SMAD7

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9085599

    2′allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.